| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Apr 01, 2024 | Sale | $962.53 | 100 | 96,253 | 18,280 | Apr 03, 2024, 04:06 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Apr 01, 2024 | Sale | $964.73 | 250 | 241,182 | 13,181 | Apr 03, 2024, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Mar 13, 2024 | Option Exercise | $637.39 | 34,217 | 21,809,565 | 68,306 | Mar 15, 2024, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Mar 14, 2024 | Sale | $956.47 | 5,783 | 5,531,290 | 53,907 | Mar 15, 2024, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Mar 01, 2024 | Sale | $982.05 | 100 | 98,205 | 18,381 | Mar 05, 2024, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Mar 01, 2024 | Sale | $967.50 | 358 | 346,365 | 13,431 | Mar 05, 2024, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Feb 26, 2024 | Sale | $990.00 | 1,000 | 990,000 | 36,543 | Feb 28, 2024, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Director | Feb 26, 2024 | Option Exercise | $702.91 | 2,000 | 1,405,830 | 26,849 | Feb 28, 2024, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Feb 26, 2024 | Option Exercise | $685.59 | 1,708 | 1,170,979 | 2,236 | Feb 26, 2024, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Feb 22, 2024 | Sale | $967.65 | 1,000 | 967,650 | 37,543 | Feb 26, 2024, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Director | Feb 23, 2024 | Sale | $699.16 | 1,000 | 699,165 | 26,849 | Feb 26, 2024, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Director | Feb 22, 2024 | Sale | $689.16 | 6,000 | 4,134,990 | 27,349 | Feb 26, 2024, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | Feb 15, 2024 | Option Exercise | $630.81 | 296,324 | 186,924,819 | 925,209 | Feb 20, 2024, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Feb 14, 2024 | Sale | $942.28 | 10,434 | 9,831,727 | 30,373 | Feb 16, 2024, 04:15 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Feb 09, 2024 | Option Exercise | $615.40 | 60,316 | 37,118,360 | 47,153 | Feb 13, 2024, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Director | Feb 09, 2024 | Sale | $684.16 | 1,000 | 684,165 | 26,849 | Feb 12, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SING GEORGE L | Director | Feb 08, 2024 | Sale | $679.16 | 1,000 | 679,165 | 26,849 | Feb 12, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Finance & CFO | Feb 09, 2024 | Sale | $953.31 | 4,919 | 4,689,320 | 18,947 | Feb 12, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Feb 07, 2024 | Sale | $950.00 | 1,000 | 950,000 | 38,543 | Feb 09, 2024, 04:12 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 07, 2024 | Sale | $950.35 | 8,037 | 7,637,954 | 59,956 | Feb 08, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Feb 02, 2024 | Option Exercise | $636.29 | 53,463 | 34,017,937 | 82,769 | Feb 06, 2024, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Feb 02, 2024 | Option Exercise | $617.34 | 681 | 420,411 | 23,974 | Feb 06, 2024, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Feb 05, 2024 | Sale | $934.71 | 1,000 | 934,710 | 13,789 | Feb 06, 2024, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Feb 01, 2024 | Sale | $954.22 | 100 | 95,422 | 18,481 | Feb 05, 2024, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Feb 01, 2024 | Sale | $945.61 | 273 | 258,152 | 14,789 | Feb 02, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 31, 2024 | Option Exercise | $616.51 | 682 | 420,456 | 23,856 | Feb 02, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Jan 30, 2024 | Sale | $669.98 | 1,654 | 1,108,139 | 2,209 | Jan 31, 2024, 04:52 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | GOLDSTEIN JOSEPH L | Director | Jan 23, 2024 | Sale | $787.80 | 5,414 | 4,265,149 | 9,089 | Jan 25, 2024, 04:18 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Jan 23, 2024 | Option Exercise | $680.51 | 17,569 | 11,955,846 | 22,874 | Jan 25, 2024, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 23, 2024 | Option Exercise | $614.56 | 1,876 | 1,152,914 | 24,084 | Jan 25, 2024, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 24, 2024 | Option Exercise | $615.41 | 852 | 524,334 | 23,808 | Jan 25, 2024, 04:17 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 17, 2024 | Option Exercise | $608.36 | 854 | 519,538 | 23,338 | Jan 18, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 12, 2024 | Option Exercise | $607.01 | 1,368 | 830,390 | 23,406 | Jan 17, 2024, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Jan 04, 2024 | Option Exercise | $597.53 | 842 | 503,121 | 22,948 | Jan 08, 2024, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Jan 03, 2024 | Option Exercise | $664.11 | 17,512 | 11,629,847 | 20,329 | Jan 04, 2024, 04:22 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Jan 03, 2024 | Option Exercise | $647.48 | 1,652 | 1,069,629 | 2,208 | Jan 04, 2024, 04:11 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Director | Jan 02, 2024 | Option Exercise | $645.96 | 2,234 | 1,443,075 | 2,364 | Jan 04, 2024, 04:11 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Director | Dec 27, 2023 | Option Exercise | $690.34 | 4,098 | 2,829,013 | 3,296 | Dec 29, 2023, 04:06 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 27, 2023 | Option Exercise | $585.89 | 1,292 | 756,973 | 22,111 | Dec 29, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 28, 2023 | Option Exercise | $590.75 | 1,462 | 863,680 | 22,419 | Dec 29, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 27, 2023 | Sale | $856.71 | 2,448 | 2,097,226 | 14,372 | Dec 29, 2023, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 22, 2023 | Sale | $846.27 | 250 | 211,568 | 16,820 | Dec 26, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 21, 2023 | Sale | $844.01 | 1,680 | 1,417,934 | 18,294 | Dec 26, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Dec 12, 2023 | Option Exercise | $856.71 | 5,105 | 4,373,505 | 15,336 | Dec 14, 2023, 04:11 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Dec 12, 2023 | Option Exercise | $856.71 | 7,657 | 6,559,829 | 48,306 | Dec 14, 2023, 04:10 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 12, 2023 | Option Exercise | $856.71 | 2,552 | 2,186,324 | 18,750 | Dec 14, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 12, 2023 | Option Exercise | $856.71 | 6,381 | 5,466,667 | 21,084 | Dec 14, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 13, 2023 | Option Exercise | $585.49 | 1,723 | 1,008,800 | 22,084 | Dec 14, 2023, 04:08 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Dec 13, 2023 | Sale | $623.35 | 1,220 | 760,481 | 1,857 | Dec 14, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | Dec 11, 2023 | Option Exercise | $844.09 | 12,841 | 10,838,960 | 752,486 | Dec 13, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | Dec 11, 2023 | Option Exercise | $844.09 | 12,841 | 10,838,960 | 374,429 | Dec 13, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Dec 08, 2023 | Option Exercise | $843.79 | 1,108 | 934,919 | 20,400 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Dec 11, 2023 | Option Exercise | $844.09 | 3,221 | 2,718,814 | 21,047 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 08, 2023 | Option Exercise | $843.79 | 809 | 682,626 | 51,891 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Dec 11, 2023 | Option Exercise | $844.09 | 725 | 611,965 | 52,019 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Dec 11, 2023 | Option Exercise | $844.09 | 5,774 | 4,873,776 | 56,632 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Dec 08, 2023 | Option Exercise | $843.79 | 883 | 745,067 | 58,538 | Dec 12, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Dec 08, 2023 | Option Exercise | $843.79 | 852 | 718,909 | 18,951 | Dec 12, 2023, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Dec 11, 2023 | Option Exercise | $841.72 | 643 | 541,224 | 20,814 | Dec 12, 2023, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Dec 11, 2023 | Option Exercise | $844.09 | 669 | 564,696 | 30,036 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Dec 08, 2023 | Option Exercise | $843.79 | 852 | 718,909 | 28,572 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 08, 2023 | Option Exercise | $843.79 | 1,013 | 854,759 | 30,686 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Dec 11, 2023 | Option Exercise | $844.09 | 3,221 | 2,718,814 | 30,017 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 08, 2023 | Option Exercise | $843.79 | 474 | 399,956 | 20,468 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Dec 11, 2023 | Option Exercise | $844.09 | 1,536 | 1,296,522 | 21,562 | Dec 12, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Dec 04, 2023 | Option Exercise | $488.96 | 33,464 | 16,362,641 | 79,421 | Dec 06, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Dec 05, 2023 | Sale | $817.44 | 6,536 | 5,342,787 | 65,821 | Dec 06, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Dec 01, 2023 | Sale | $817.30 | 100 | 81,730 | 18,546 | Dec 04, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Nov 14, 2023 | Sale | $799.17 | 6,492 | 5,188,213 | 65,161 | Nov 15, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Nov 13, 2023 | Option Exercise | $482.18 | 33,508 | 16,156,780 | 79,421 | Nov 15, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Nov 07, 2023 | Sale | $827.90 | 100 | 82,790 | 18,641 | Nov 08, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Nov 01, 2023 | Sale | $582.65 | 2,000 | 1,165,310 | 20,803 | Nov 02, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Director | Oct 13, 2023 | Sale | $620.96 | 2,000 | 1,241,920 | 2,247 | Oct 17, 2023, 04:06 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Oct 02, 2023 | Sale | $599.73 | 2,076 | 1,245,039 | 20,841 | Oct 03, 2023, 04:04 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Sep 01, 2023 | Sale | $834.55 | 250 | 208,637 | 19,803 | Sep 06, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Aug 23, 2023 | Option Exercise | $588.44 | 12,198 | 7,177,767 | 26,140 | Aug 25, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Aug 23, 2023 | Sale | $844.00 | 223 | 188,212 | 31,699 | Aug 25, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | POON CHRISTINE A | Director | Aug 23, 2023 | Sale | $556.82 | 24,560 | 13,675,497 | 14,317 | Aug 25, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Aug 23, 2023 | Option Exercise | $576.35 | 40,053 | 23,084,423 | 44,633 | Aug 25, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Van Plew Daniel P | EVP & General Mgr, Industrial | Aug 24, 2023 | Sale | $841.71 | 6,197 | 5,216,073 | 27,567 | Aug 25, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 21, 2023 | Option Exercise | $587.89 | 88,335 | 51,931,006 | 103,100 | Aug 23, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | STAHL NEIL | EVP Research and Development | Aug 22, 2023 | Sale | $840.98 | 11,665 | 9,810,082 | 58,456 | Aug 23, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Aug 21, 2023 | Option Exercise | $610.46 | 1,706 | 1,041,445 | 2,100 | Aug 23, 2023, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Aug 10, 2023 | Option Exercise | $590.46 | 1,706 | 1,007,325 | 2,100 | Aug 11, 2023, 04:13 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Aug 01, 2023 | Sale | $736.59 | 100 | 73,659 | 18,745 | Aug 03, 2023, 04:25 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Aug 01, 2023 | Sale | $744.66 | 250 | 186,165 | 20,053 | Aug 03, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Jul 03, 2023 | Sale | $710.09 | 250 | 177,523 | 20,303 | Jul 06, 2023, 04:02 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Jul 03, 2023 | Sale | $716.88 | 100 | 71,688 | 18,846 | Jul 06, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Jun 01, 2023 | Sale | $735.42 | 100 | 73,542 | 18,945 | Jun 02, 2023, 04:14 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Jun 01, 2023 | Sale | $736.00 | 250 | 184,000 | 20,553 | Jun 02, 2023, 04:12 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | May 01, 2023 | Sale | $805.33 | 100 | 80,533 | 19,031 | May 03, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | BROWN MICHAEL S | Director | Apr 21, 2023 | Option Exercise | $659.21 | 6,140 | 4,047,580 | 4,317 | Apr 24, 2023, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Apr 03, 2023 | Sale | $819.31 | 100 | 81,931 | 19,140 | Apr 05, 2023, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | McCourt Marion | EVP Commercial | Apr 03, 2023 | Sale | $595.63 | 2,200 | 1,310,386 | 21,903 | Apr 05, 2023, 04:00 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 28, 2023 | Sale | $823.47 | 1,007 | 829,233 | 32,919 | Mar 29, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Landry Robert E | EVP Finance CFO | Mar 27, 2023 | Sale | $575.20 | 6,776 | 3,897,548 | 35,316 | Mar 29, 2023, 04:07 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Bassler Bonnie L | Director | Mar 24, 2023 | Option Exercise | $599.48 | 2,480 | 1,486,698 | 2,487 | Mar 27, 2023, 04:43 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | YANCOPOULOS GEORGE | President and Chief Scientific | Mar 23, 2023 | Sale | $804.26 | 3,656 | 2,940,374 | 200,250 | Mar 27, 2023, 04:41 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | LAROSA JOSEPH J | EVP General Counsel and Secret | Mar 23, 2023 | Option Exercise | $484.33 | 16,742 | 8,108,620 | 34,213 | Mar 27, 2023, 04:39 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | SVP Controller | Mar 23, 2023 | Sale | $806.47 | 2,192 | 1,767,782 | 18,409 | Mar 27, 2023, 04:37 PM |
Menu